Search

Your search keyword '"Lumretuzumab"' showing total 2 results
Start Over Descriptor "Lumretuzumab" Journal annals of oncology
2 results on '"Lumretuzumab"'

1. A phase Ib study of lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with carboplatin and paclitaxel as 1st-line treatment in patients with squamous non-small cell lung cancer

Author

Celine Adessi, Wolfgang Jacob, A. Navarro Mendivil, M. Mau Soerensen, Enriqueta Felip, Francesca Michielin, T. Fleitas, Álvaro Taus, Ian James, U. Lassen, Natasha B. Leighl, Martin Weisser, J.M. Cejalvo, Andrés Cervantes, Maria Martinez-Garcia, and Maurizio Ceppi

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, medicine.drug_class, Hematology, Lumretuzumab, Monoclonal antibody, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 030104 developmental biology, 0302 clinical medicine, chemistry, Paclitaxel, 030220 oncology & carcinogenesis, Internal medicine, Squamous non-small cell lung cancer, Medicine, In patient, Line (text file), business
Published
2016
Full Text
View/download PDF

2. Impact of tumor heregulin mRNA expression on outcome of patients with advanced/metastatic squamous NSCLC treated with lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with erlotinib

Author

Álvaro Taus, M. Sorensen, Andrés Cervantes, Maria Martinez-Garcia, Sang We Kim, Birgit Bossenmaier, Ian James, Martin Weisser, J.H.M. Schellens, Enriqueta Felip, Didier Meulendijks, U. Lassen, Celine Adessi, Wolfgang Jacob, Francesca Michielin, Antonio Calles, Georgina Meneses-Lorente, T. Fleitas, J.-Y. Han, and Maurizio Ceppi

Subjects
Oncology, medicine.medical_specialty, medicine.drug_class, business.industry, Mrna expression, Hematology, Lumretuzumab, Monoclonal antibody, Internal medicine, medicine, Neuregulin, Erlotinib, business, medicine.drug
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results